Blog
RSS FeedPosted by Michael Wonder on 18 Mar 2024
Co-design of an enhanced consumer engagement process
18 March 2024 - A consumer-led Co-design Working Group has developed proposed recommendations for enhancing consumer engagement processes to enable ...
Posted by Michael Wonder on 20 Sep 2023
International HTA collaboration expands
20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...
Posted by Michael Wonder on 05 Sep 2022
Collaboration arrangement between the Department of Health and Aged Care and Health Technology Assessment bodies in the United Kingdom and Canada
5 September 2022 - The Department of Health and Aged Care has signed an international collaboration arrangement with five like minded ...
Posted by Michael Wonder on 07 Feb 2022
Mentoring as a potential means to assist consumer representatives contribute effectively to the assessment of health technologies in Australia: a pragmatic review
7 February 2022 - This project was implemented on behalf of the Health Technology Assessment Consumer Consultative Committee to explore training ...
Posted by Michael Wonder on 09 Sep 2021
MSD Australia endorses new medicines strategic agreement
8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...
Posted by Michael Wonder on 07 Sep 2021
Landmark new medicines agreements to bring significant benefits for Australian patients
7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...
Posted by Michael Wonder on 07 Sep 2021
New strategic agreements with the medicines industry
7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...
Posted by Michael Wonder on 06 Sep 2021
Leap forward for patients accessing medicines
7 September 2021 - Medicines Australia has secured a 5 year strategic agreement with the Federal Government, centered on earlier ...
Posted by Michael Wonder on 10 May 2021
The Government and Medicines Australia jointly agree to finalise patient centric strategic agreement after the Budget
8 May 2021 - Medicines Australia has been working closely with the Minister and his Department since last year to ...
Posted by Michael Wonder on 31 Jan 2021
Evaluation of the impact of patient input in health technology assessments at NICE
29 January 2021 - Accounts of patient experiences are increasingly used in health technology assessment processes. However, we know little about ...
Posted by Michael Wonder on 29 Sep 2020
Australian patients to benefit from ongoing collaboration between peak medicine bodies
29 September 2020 - ACCC extends conditional authorisation to Medicines Australia and the Generic and Biosimilar Medicines Association ...
Posted by Michael Wonder on 14 May 2020
Consumer comments needed for proposed new listings on the PBS
12 May 2020 - Lung Foundation Australia is seeking input from consumers to inform submissions on proposed listings of respiratory ...
Posted by Michael Wonder on 06 May 2020
Medicines Australia joins forces with 15 health care organisations to highlight continuity of care
6 May 2020 - Right now, more than ever, it is essential that Australians maintain their health. Therefore, Medicines Australia ...
Posted by Michael Wonder on 26 Apr 2020
Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies
26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...
Posted by Michael Wonder on 06 Apr 2020
Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC
3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today ...